About: Bryan L. Roth

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Bryan L. Roth Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

American pharmacologist

Attributes	Values
rdf:type	Item
description	ikertzailea (eu) 연구원 (ko) wetenschapper (nl) дослідник (uk) изилдөөчү (ky) American pharmacologist (en) farmacólogo estadounidense (es) عالم صيدلية أمريكي (ar)
rdfs:label	Bryan L Roth (nl) Bryan L. Roth (en)
skos:prefLabel	Bryan L Roth (nl) Bryan L. Roth (en)
name	Bryan L Roth (nl) Bryan L. Roth (en)
given name	wds:Q89688393-D0FF9C71-BB64-46B7-8F27-7F503BB4E3C1
given name	Bryan
instance of	wds:Q89688393-29CA35D1-D280-49A2-8A92-F03B019FBB90
instance of	Homo sapiens
Google Knowledge Graph ID	wds:Q89688393-B5E8DF10-D2C2-432B-95C7-46762924C7AE
Google Knowledge Graph ID	http://g.co/kg/g/12nxfs293
Google Knowledge Graph ID	/g/12nxfs293
skos:altLabel	Bryan Roth (en) Bryan L Roth (en)
occupation	wds:Q89688393-8BFCCC68-2EC7-4DB3-AAF5-844E7011125E
CiNii Research ID	wds:Q89688393-23E2A104-2E83-49B6-ACA8-EE35751B2492
sex or gender	wds:Q89688393-D40EEB78-6806-4F90-8B60-7F4E967EFC3F
ISNI	wds:Q89688393-c6a3c5ca-4605-7311-0ec6-7c4784d19650
VIAF ID	wds:Q89688393-26cc97b0-48d8-ad1f-b96a-3d2628d13ac3
Library of Congress authority ID	wds:Q89688393-b376b19d-48b2-3121-6707-9a7a61dcab18
IdRef ID	wds:Q89688393-e84bc45e-4873-4114-6cfe-ad60397004b9
NACSIS-CAT author ID	wds:Q89688393-6f365ea2-49b9-b0e3-3335-a551c54a295d
on focus list of Wikimedia project	wds:Q89688393-37E0E130-3E46-4502-B0AB-6B63B582652B
family name	wds:Q89688393-0335DCFD-7782-40BC-95DF-B0CA56CF85EF
Canadiana Name Authority ID	wds:Q89688393-cd9cd43b-4fc5-e39c-b4b6-f3cb653f3bba
National Library of Israel J9U ID	wds:Q89688393-e940fc91-4c28-9d9e-1132-4d07fcdeeb0e
CiNii Research ID	https://cir.nii.ac.jp/crid/1140282266643169536.rdf
VIAF ID	http://viaf.org/viaf/75400848
Library of Congress authority ID	http://id.loc.gov/authorities/names/n88090516
IdRef ID	http://www.idref.fr/106955667/id
NACSIS-CAT author ID	https://ci.nii.ac.jp/author/DA04035470#entity
occupation	researcher
CiNii Research ID	1140282266643169536
sex or gender	male
ISNI	0000000055596359
VIAF ID	75400848
Library of Congress authority ID	n88090516
IdRef ID	106955667
NACSIS-CAT author ID	DA04035470
on focus list of Wikimedia project	WikiProject COVID-19
family name	Roth
Canadiana Name Authority ID	ncf11487910
National Library of Israel J9U ID	987007364516305171
ORCID iD	wds:Q89688393-B260A6B4-97F6-4A8D-A3E3-2231F7CB1546
ORCID iD	https://orcid.org/0000-0002-0561-6520
ORCID iD	0000-0002-0561-6520
ORKG ID	wds:Q89688393-bdc3b7d3-7025-4d12-9f77-4118126b91a9
ORKG ID	R51339
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q89688393 Bryan Roth
is author of	Allosteric sodium in class A GPCR signaling H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Structure of the human κ-opioid receptor in complex with JDTic Structural Basis for Molecular Recognition at Serotonin Receptors Structural Features for Functional Selectivity at Serotonin Receptors Structure of the human smoothened receptor bound to an antitumour agent Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs Structural Determinants of G-protein Subunit Selectivity by Regulator of G-protein Signaling 2 (RGS2) Comprehensive characterization of the Published Kinase Inhibitor Set Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo Structural basis for bifunctional peptide recognition at human δ-opioid receptor Erratum: Corrigendum: The promise and peril of chemical probes The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine's actions? Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugs Molecular control of δ-opioid receptor signalling Ligand discovery from a dopamine D3 receptor homology model and crystal structure Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor Chemotype-selective modes of action of κ-opioid receptor agonists Development, validation, and use of quantitative structure-activity relationship models of 5-hydroxytryptamine (2B) receptor ligands to identify novel receptor binders and putative valvulopathic compounds among common drugs Structural insights into the extracellular recognition of the human serotonin 2B receptor by an antibody Application of quantitative structure-activity relationship models of 5-HT1A receptor binding to virtual screening identifies novel and potent 5-HT1A ligands Unexplored therapeutic opportunities in the human genome. Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor. 5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice. 5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology. Structural determinants of 5-HT2B receptor activation and biased agonism XFEL structures of the human MT2 melatonin receptor reveal the basis of subtype selectivity Structural basis of ligand recognition at the human MT1 melatonin receptor Unexplored therapeutic opportunities in the human genome A SARS-CoV-2 protein interaction map reveals targets for drug repurposing D4 dopamine receptor high-resolution structures enable the discovery of selective agonists. Molecular pharmacology of metabotropic receptors targeted by neuropsychiatric drugs Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome Structure, function and pharmacology of human itch GPCRs The activities of drug inactive ingredients on biological targets Defining Structure-Functional Selectivity Relationships (SFSR) for a Class of Non-Catechol Dopamine D1 Receptor Agonists Discrepancies in Kappa Opioid Agonist Binding Revealed through PET Imaging D2 Dopamine Receptor G Protein-Biased Partial Agonists Based on Cariprazine

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software